Amnio Technology News
Amnio Technology Awarded MedTech Wound Care’s Top 10 Solution Providers of 2019
PHOENIX, December 16, 2019 — Amnio Technology, LLC, a leading manufacturer of advanced regenerative allografts derived from human amniotic tissues, is honored to have been awarded MedTech Wound Care's Top 10 Solution Providers of 2019. About Amnio Technology, LLC...
Amnio Technology announces national launch of PalinGen® InovōFlo™ to supplement tissue for protection, cushioning and lubrication
PHOENIX, Sept. 5, 2017 /PRNewswire/ -- Amnio Technology, LLC, a leading manufacturer of advanced regenerative allografts derived from human amniotic tissues, announced today the expansion of its product line with the launch of PalinGen® InovōFlo™. PalinGen®...
Amnio Technology’s PalinGen® and ProMatrX® Lines Assigned Q Codes for Product Reimbursement
FOR IMMEDIATE RELEASE: Amnio Technology’s PalinGen® and ProMatrX® Lines Assigned Q Codes for Product Reimbursement Phoenix, AZ, USA (November 14, 2016) – Amnio Technology, LLC, a leading manufacturer of advanced regenerative allografts derived from human...
Amnio Technology Announces PalinGen® and ProMatrX™ Product Coverage by Palmetto GBA
FOR IMMEDIATE RELEASE: Amnio Technology Announces PalinGen® and ProMatrX™ Product Coverage by Palmetto GBA Phoenix, AZ, USA (June 15, 2016) – Amnio Technology, a manufacturer and distributor of amnion-derived human allografts, announced today that Palmetto...
Amnio Technology receives first US Patent for placental tissue allograft
Accelular amnion derived therapeutic compositions. Amnion derived materials are being used to treat a wide array of conditions such as to promote tissue healing.
Amnio Technology News
Amnio Technology Awarded MedTech Wound Care’s Top 10 Solution Providers of 2019
PHOENIX, December 16, 2019 — Amnio Technology, LLC, a leading manufacturer of advanced regenerative allografts derived from human amniotic tissues, is honored to have been awarded MedTech Wound Care's Top 10 Solution Providers of 2019. About Amnio Technology, LLC...
Amnio Technology announces national launch of PalinGen® InovōFlo™ to supplement tissue for protection, cushioning and lubrication
PHOENIX, Sept. 5, 2017 /PRNewswire/ -- Amnio Technology, LLC, a leading manufacturer of advanced regenerative allografts derived from human amniotic tissues, announced today the expansion of its product line with the launch of PalinGen® InovōFlo™. PalinGen®...
Amnio Technology’s PalinGen® and ProMatrX® Lines Assigned Q Codes for Product Reimbursement
FOR IMMEDIATE RELEASE: Amnio Technology’s PalinGen® and ProMatrX® Lines Assigned Q Codes for Product Reimbursement Phoenix, AZ, USA (November 14, 2016) – Amnio Technology, LLC, a leading manufacturer of advanced regenerative allografts derived from human...
Amnio Technology Announces PalinGen® and ProMatrX™ Product Coverage by Palmetto GBA
FOR IMMEDIATE RELEASE: Amnio Technology Announces PalinGen® and ProMatrX™ Product Coverage by Palmetto GBA Phoenix, AZ, USA (June 15, 2016) – Amnio Technology, a manufacturer and distributor of amnion-derived human allografts, announced today that Palmetto...
Amnio Technology receives first US Patent for placental tissue allograft
Accelular amnion derived therapeutic compositions. Amnion derived materials are being used to treat a wide array of conditions such as to promote tissue healing.